Shed Review
Flexible GLP-1 access with both compounded and brand-name medication options
Last updated April 2026 · Read our methodology
- Both compounded and brand-name medication options under one platform
- Competitive compounded semaglutide pricing from $199/mo
- No subscription fee for compounded medication plans
- Access to brand-name Wegovy and Zepbound for patients with insurance
- Straightforward online consultation process
- Wide range of GLP-1 content and educational resources
- 2-month minimum commitment required
- $99/mo subscription fee on top of brand-name medication costs
- Less structured coaching or behavioral support than holistic programs
- Cancellation must be 72+ hours before next billing date
- Limited published clinical outcome data specific to their patients
| Scoring Criterion | Score / 10 |
|---|---|
| Clinical Effectiveness | 8.0 |
| Cost & Transparency | 8.0 |
| Program Comprehensiveness | 7.5 |
| Accessibility & Convenience | 8.0 |
| Customer Satisfaction | 7.5 |
What They Offer
Shed is a telehealth platform offering GLP-1 weight loss treatment through both compounded and brand-name medication tracks. For compounded medications, patients can access semaglutide starting at $199/mo or tirzepatide starting at $299/mo — no subscription fee required beyond the medication cost. For patients with insurance, Shed also prescribes brand-name Wegovy and Zepbound with a $99/mo subscription fee that covers the telehealth platform and ongoing provider access. The company operates on a subscription model with a two-month minimum commitment, after which patients can cancel with 72 hours' notice before their next billing date.
Pricing & Plans
| Plan | Price | Includes |
|---|---|---|
| Compounded Semaglutide | From $199/mo | Telehealth consultation, compounded semaglutide, ongoing support |
| Compounded Tirzepatide | From $299/mo | Telehealth consultation, compounded tirzepatide, ongoing support |
| Brand-Name (Wegovy/Zepbound) | $99/mo + Rx cost | Platform subscription, provider access, brand-name prescription |
What's Included
- Online provider consultation
- Compounded or brand-name GLP-1 prescription
- Ongoing provider access for dose adjustments
- Medication delivery coordination
- Educational blog content and resources
- Prescription management and renewals
Eligibility
BMI 30+ OR BMI 27+ with a weight-related health condition. Must be 18+. Available in most states (check website for current coverage). Standard GLP-1 contraindications apply including personal or family history of medullary thyroid cancer or MEN2 syndrome.
Clinical Results & Effectiveness
Shed prescribes the same GLP-1 medications studied in major clinical trials. Compounded semaglutide and tirzepatide target the same biological pathways as their brand-name counterparts (Wegovy, Zepbound), with published trial data showing 15–20% body weight reduction over treatment periods. For patients on brand-name medications through Shed, outcomes align directly with FDA-approved labeling. Independent clinical data specific to Shed's patient population has not been published.
Customer Experience
Shed receives generally positive feedback for its straightforward approach. The dual-track model (compounded plus brand-name) gives patients flexibility that many competitors lack — you can start with more affordable compounded medication and potentially transition to brand-name if insurance comes through. The 2-month minimum commitment is a minor friction point compared to platforms offering month-to-month flexibility. The platform's blog and educational content are thorough, suggesting an investment in patient education beyond just prescribing.
Our Verdict
Shed makes practical sense for patients who want optionality. If you are not sure whether you will end up on compounded or brand-name GLP-1, or you want the flexibility to switch, Shed accommodates both under one roof. The compounded semaglutide pricing at $199/mo is competitive, and the lack of a subscription fee on compounded plans keeps the total cost straightforward. The brand-name track's $99/mo subscription adds a layer of cost that some patients may find redundant if their insurance already covers the medication, but it includes ongoing provider access. For straightforward medication access with room to evolve your treatment, Shed is a solid mid-tier choice.
Get Started →Disclosures
Affiliate Disclosure: GLP1Authority.com may earn commissions from referrals or affiliate partnerships. This review reflects our independent assessment and does not influence our ratings.
Medical Disclaimer: This review is for informational purposes only and does not constitute medical advice. Please consult with a healthcare provider before starting any GLP-1 weight loss program.
References
Stay Informed
Get the GLP-1 Insider Brief
Exclusive provider discounts, healthy living guides for your GLP-1 journey, and the latest breakthroughs in peptide science — delivered free.
No spam. Unsubscribe any time.